Review





Similar Products

93
TaKaRa epixplore methylated dna enrichment kit
Epixplore Methylated Dna Enrichment Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/methylated+dna/EpiXplore+Methylated+DNA+Enrichment+Kit/pm42525506-50-10-15
Average 93 stars, based on 1 article reviews
epixplore methylated dna enrichment kit - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

99
Zymo Research ez dna methylation lightning kit
Ez Dna Methylation Lightning Kit, supplied by Zymo Research, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/methylated+dna/EZ+DNA+Methylation-Lightning+Kit/10__3390_slash_genes17101181-75-5-9
Average 99 stars, based on 1 article reviews
ez dna methylation lightning kit - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
Zymo Research ez dna methylation kit
(A) <t>Methylation</t> index, calculated as the ratio of SAM to SAH), of OVCAR3 across a time course of platinum (cisplatin, CDDP) treatment (3, 8 and 16 hours) (B) Global 5-methylcytosine (5-mC) levels of OVCAR3 cells untreated (UT) or treated with CDDP (15μM, 16 hours) measured by ELISA and normalized to total level of <t>DNA.</t> (C) ssGSEA-derived ΔDNMT1 (left) and ΔDNMT3A (right) scores plotted against ΔMAT2A expression between matched recurrent and primary tumors stratified by MAT2A-high (red) and MAT2A-low (blue) patients. (D) Heatmap of beta values for statistically significant (adjusted p<0.05) differentially methylated probes identified between siScramble and CDDP-treated conditions. (E) Volcano plot of CpG-level methylation changes between CDDP-treated and siScramble control cells. Each point represents a single CpG site; blue points indicate statistically significant differential β-value (adjusted p < 0.05, Δβ> 0.05); red points indicate β-value changes below statistical significance; yellow points indicate statistically significant but Δβ-value < 0.05. Positive and negative β-value denote hypermethylation and hypomethylation in CDDP versus siScramble, respectively. (F) Pie chart of the distribution of hypermethylated CpG to gene features (promoter, exon, intron, and intergenic regions) in CDDP versus siScramble. (G) Pie chart of genomic annotation of differentially methylated regions (DMRs) across CpG island contextual categories (island, shore, shelf, and open sea) in CDDP versus siScramble. (H) Ingenuity Pathway Analysis (IPA) of biological pathways enriched among DMR-associated genes identified from the CDDP versus siScramble. (* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001; ns, not significant)
Ez Dna Methylation Kit, supplied by Zymo Research, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/methylated+dna/EZ+DNA+Methylation-Lightning+Kit/bio_rxiv__64898__2026__09__22__753550-75-11-15
Average 99 stars, based on 1 article reviews
ez dna methylation kit - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
Zymo Research ez dna methylation-gold kit
(A) <t>Methylation</t> index, calculated as the ratio of SAM to SAH), of OVCAR3 across a time course of platinum (cisplatin, CDDP) treatment (3, 8 and 16 hours) (B) Global 5-methylcytosine (5-mC) levels of OVCAR3 cells untreated (UT) or treated with CDDP (15μM, 16 hours) measured by ELISA and normalized to total level of <t>DNA.</t> (C) ssGSEA-derived ΔDNMT1 (left) and ΔDNMT3A (right) scores plotted against ΔMAT2A expression between matched recurrent and primary tumors stratified by MAT2A-high (red) and MAT2A-low (blue) patients. (D) Heatmap of beta values for statistically significant (adjusted p<0.05) differentially methylated probes identified between siScramble and CDDP-treated conditions. (E) Volcano plot of CpG-level methylation changes between CDDP-treated and siScramble control cells. Each point represents a single CpG site; blue points indicate statistically significant differential β-value (adjusted p < 0.05, Δβ> 0.05); red points indicate β-value changes below statistical significance; yellow points indicate statistically significant but Δβ-value < 0.05. Positive and negative β-value denote hypermethylation and hypomethylation in CDDP versus siScramble, respectively. (F) Pie chart of the distribution of hypermethylated CpG to gene features (promoter, exon, intron, and intergenic regions) in CDDP versus siScramble. (G) Pie chart of genomic annotation of differentially methylated regions (DMRs) across CpG island contextual categories (island, shore, shelf, and open sea) in CDDP versus siScramble. (H) Ingenuity Pathway Analysis (IPA) of biological pathways enriched among DMR-associated genes identified from the CDDP versus siScramble. (* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001; ns, not significant)
Ez Dna Methylation Gold Kit, supplied by Zymo Research, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/methylated+dna/EZ+DNA+Methylation-Gold+Kit/custom%40d5005%4042484787
Average 99 stars, based on 1 article reviews
ez dna methylation-gold kit - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
Miltenyi Biotec dna methylation
(A) <t>Methylation</t> index, calculated as the ratio of SAM to SAH), of OVCAR3 across a time course of platinum (cisplatin, CDDP) treatment (3, 8 and 16 hours) (B) Global 5-methylcytosine (5-mC) levels of OVCAR3 cells untreated (UT) or treated with CDDP (15μM, 16 hours) measured by ELISA and normalized to total level of <t>DNA.</t> (C) ssGSEA-derived ΔDNMT1 (left) and ΔDNMT3A (right) scores plotted against ΔMAT2A expression between matched recurrent and primary tumors stratified by MAT2A-high (red) and MAT2A-low (blue) patients. (D) Heatmap of beta values for statistically significant (adjusted p<0.05) differentially methylated probes identified between siScramble and CDDP-treated conditions. (E) Volcano plot of CpG-level methylation changes between CDDP-treated and siScramble control cells. Each point represents a single CpG site; blue points indicate statistically significant differential β-value (adjusted p < 0.05, Δβ> 0.05); red points indicate β-value changes below statistical significance; yellow points indicate statistically significant but Δβ-value < 0.05. Positive and negative β-value denote hypermethylation and hypomethylation in CDDP versus siScramble, respectively. (F) Pie chart of the distribution of hypermethylated CpG to gene features (promoter, exon, intron, and intergenic regions) in CDDP versus siScramble. (G) Pie chart of genomic annotation of differentially methylated regions (DMRs) across CpG island contextual categories (island, shore, shelf, and open sea) in CDDP versus siScramble. (H) Ingenuity Pathway Analysis (IPA) of biological pathways enriched among DMR-associated genes identified from the CDDP versus siScramble. (* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001; ns, not significant)
Dna Methylation, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/methylated+dna/Dead+Cell+Removal+Kit/pm42337581-39-14-34
Average 99 stars, based on 1 article reviews
dna methylation - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

86
Pyrosequencing Inc dna pyrosequencing methylation assays
(A) <t>Methylation</t> index, calculated as the ratio of SAM to SAH), of OVCAR3 across a time course of platinum (cisplatin, CDDP) treatment (3, 8 and 16 hours) (B) Global 5-methylcytosine (5-mC) levels of OVCAR3 cells untreated (UT) or treated with CDDP (15μM, 16 hours) measured by ELISA and normalized to total level of <t>DNA.</t> (C) ssGSEA-derived ΔDNMT1 (left) and ΔDNMT3A (right) scores plotted against ΔMAT2A expression between matched recurrent and primary tumors stratified by MAT2A-high (red) and MAT2A-low (blue) patients. (D) Heatmap of beta values for statistically significant (adjusted p<0.05) differentially methylated probes identified between siScramble and CDDP-treated conditions. (E) Volcano plot of CpG-level methylation changes between CDDP-treated and siScramble control cells. Each point represents a single CpG site; blue points indicate statistically significant differential β-value (adjusted p < 0.05, Δβ> 0.05); red points indicate β-value changes below statistical significance; yellow points indicate statistically significant but Δβ-value < 0.05. Positive and negative β-value denote hypermethylation and hypomethylation in CDDP versus siScramble, respectively. (F) Pie chart of the distribution of hypermethylated CpG to gene features (promoter, exon, intron, and intergenic regions) in CDDP versus siScramble. (G) Pie chart of genomic annotation of differentially methylated regions (DMRs) across CpG island contextual categories (island, shore, shelf, and open sea) in CDDP versus siScramble. (H) Ingenuity Pathway Analysis (IPA) of biological pathways enriched among DMR-associated genes identified from the CDDP versus siScramble. (* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001; ns, not significant)
Dna Pyrosequencing Methylation Assays, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/methylated+dna/analysis+methylation+pyrosequencing+quantitative+universal/us12655484-167-3-4
Average 86 stars, based on 1 article reviews
dna pyrosequencing methylation assays - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

94
Vazyme Biotech Co epiart dna methylation library kit for illumina v3
(A) <t>Methylation</t> index, calculated as the ratio of SAM to SAH), of OVCAR3 across a time course of platinum (cisplatin, CDDP) treatment (3, 8 and 16 hours) (B) Global 5-methylcytosine (5-mC) levels of OVCAR3 cells untreated (UT) or treated with CDDP (15μM, 16 hours) measured by ELISA and normalized to total level of <t>DNA.</t> (C) ssGSEA-derived ΔDNMT1 (left) and ΔDNMT3A (right) scores plotted against ΔMAT2A expression between matched recurrent and primary tumors stratified by MAT2A-high (red) and MAT2A-low (blue) patients. (D) Heatmap of beta values for statistically significant (adjusted p<0.05) differentially methylated probes identified between siScramble and CDDP-treated conditions. (E) Volcano plot of CpG-level methylation changes between CDDP-treated and siScramble control cells. Each point represents a single CpG site; blue points indicate statistically significant differential β-value (adjusted p < 0.05, Δβ> 0.05); red points indicate β-value changes below statistical significance; yellow points indicate statistically significant but Δβ-value < 0.05. Positive and negative β-value denote hypermethylation and hypomethylation in CDDP versus siScramble, respectively. (F) Pie chart of the distribution of hypermethylated CpG to gene features (promoter, exon, intron, and intergenic regions) in CDDP versus siScramble. (G) Pie chart of genomic annotation of differentially methylated regions (DMRs) across CpG island contextual categories (island, shore, shelf, and open sea) in CDDP versus siScramble. (H) Ingenuity Pathway Analysis (IPA) of biological pathways enriched among DMR-associated genes identified from the CDDP versus siScramble. (* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001; ns, not significant)
Epiart Dna Methylation Library Kit For Illumina V3, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/methylated+dna/EpiArt+DNA+Methylation+Library+Kit+for+Illumina+V3/custom%40ne103%4042272047
Average 94 stars, based on 1 article reviews
epiart dna methylation library kit for illumina v3 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

Image Search Results


(A) Methylation index, calculated as the ratio of SAM to SAH), of OVCAR3 across a time course of platinum (cisplatin, CDDP) treatment (3, 8 and 16 hours) (B) Global 5-methylcytosine (5-mC) levels of OVCAR3 cells untreated (UT) or treated with CDDP (15μM, 16 hours) measured by ELISA and normalized to total level of DNA. (C) ssGSEA-derived ΔDNMT1 (left) and ΔDNMT3A (right) scores plotted against ΔMAT2A expression between matched recurrent and primary tumors stratified by MAT2A-high (red) and MAT2A-low (blue) patients. (D) Heatmap of beta values for statistically significant (adjusted p<0.05) differentially methylated probes identified between siScramble and CDDP-treated conditions. (E) Volcano plot of CpG-level methylation changes between CDDP-treated and siScramble control cells. Each point represents a single CpG site; blue points indicate statistically significant differential β-value (adjusted p < 0.05, Δβ> 0.05); red points indicate β-value changes below statistical significance; yellow points indicate statistically significant but Δβ-value < 0.05. Positive and negative β-value denote hypermethylation and hypomethylation in CDDP versus siScramble, respectively. (F) Pie chart of the distribution of hypermethylated CpG to gene features (promoter, exon, intron, and intergenic regions) in CDDP versus siScramble. (G) Pie chart of genomic annotation of differentially methylated regions (DMRs) across CpG island contextual categories (island, shore, shelf, and open sea) in CDDP versus siScramble. (H) Ingenuity Pathway Analysis (IPA) of biological pathways enriched among DMR-associated genes identified from the CDDP versus siScramble. (* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001; ns, not significant)

Journal: bioRxiv

Article Title: Targeting MAT2A-S-adenosylmethionine (SAM) Axis Attenuates DNA Damage Response and Cancer Stemness to Increase Platinum Sensitivity in Ovarian Cancer

doi: 10.64898/2026.09.22.753550

Figure Lengend Snippet: (A) Methylation index, calculated as the ratio of SAM to SAH), of OVCAR3 across a time course of platinum (cisplatin, CDDP) treatment (3, 8 and 16 hours) (B) Global 5-methylcytosine (5-mC) levels of OVCAR3 cells untreated (UT) or treated with CDDP (15μM, 16 hours) measured by ELISA and normalized to total level of DNA. (C) ssGSEA-derived ΔDNMT1 (left) and ΔDNMT3A (right) scores plotted against ΔMAT2A expression between matched recurrent and primary tumors stratified by MAT2A-high (red) and MAT2A-low (blue) patients. (D) Heatmap of beta values for statistically significant (adjusted p<0.05) differentially methylated probes identified between siScramble and CDDP-treated conditions. (E) Volcano plot of CpG-level methylation changes between CDDP-treated and siScramble control cells. Each point represents a single CpG site; blue points indicate statistically significant differential β-value (adjusted p < 0.05, Δβ> 0.05); red points indicate β-value changes below statistical significance; yellow points indicate statistically significant but Δβ-value < 0.05. Positive and negative β-value denote hypermethylation and hypomethylation in CDDP versus siScramble, respectively. (F) Pie chart of the distribution of hypermethylated CpG to gene features (promoter, exon, intron, and intergenic regions) in CDDP versus siScramble. (G) Pie chart of genomic annotation of differentially methylated regions (DMRs) across CpG island contextual categories (island, shore, shelf, and open sea) in CDDP versus siScramble. (H) Ingenuity Pathway Analysis (IPA) of biological pathways enriched among DMR-associated genes identified from the CDDP versus siScramble. (* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001; ns, not significant)

Article Snippet: For methylation analysis, 500 ng of DNA was bisulfite-converted using the EZ DNA Methylation Kit (Zymo Research, cat. D5031) following the manufacturer’s instructions.

Techniques: Methylation, Platinum, Enzyme-linked Immunosorbent Assay, Derivative Assay, Expressing, Control, Analysis, Significance Assay